Aurinia Pharmaceuticals Inc. (AUPH)
After hours:
| Previous close | 5.16 |
| Open | 5.14 |
| Bid | 5.08 x 400 |
| Ask | 5.17 x 100 |
| Day's range | 5.05 - 5.20 |
| 52-week range | 4.71 - 12.43 |
| Volume | |
| Avg. volume | 2,145,632 |
| Market cap | 732.257M |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.43 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.86 |
ZacksHow Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
The average of price targets set by Wall Street analysts indicates a potential upside of 96.5% in Aurinia (AUPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Business WireAurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
ROCKVILLE, Md. & EDMONTON, Alberta, May 07, 2024--Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
Insider MonkeyAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript May 2, 2024 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17. AUPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Aurinia […]
